Clinical trial
Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic…
NCT00049101 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00049101 |
|---|---|
| Title | Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer |
| Official title | A Phase I/II Study Of OSI-774 In Combination With Oxaliplatin, And 5-Fluourouracil In Patients With Metastatic Colorectal Carcinoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | erlotinib hydrochloride, fluorouracil, leucovorin calcium, oxaliplatin |
| Start date | Aug 1, 2002 |
| Completion | Aug 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: